These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30972970)

  • 1. Anxa2- and Ctsd-knockout CHO cell lines to diminish the risk of contamination with host cell proteins.
    Fukuda N; Senga Y; Honda S
    Biotechnol Prog; 2019 Jul; 35(4):e2820. PubMed ID: 30972970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trace levels of the CHO host cell protease cathepsin D caused particle formation in a monoclonal antibody product.
    Bee JS; Tie L; Johnson D; Dimitrova MN; Jusino KC; Afdahl CD
    Biotechnol Prog; 2015; 31(5):1360-9. PubMed ID: 26259961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockout of a difficult-to-remove CHO host cell protein, lipoprotein lipase, for improved polysorbate stability in monoclonal antibody formulations.
    Chiu J; Valente KN; Levy NE; Min L; Lenhoff AM; Lee KH
    Biotechnol Bioeng; 2017 May; 114(5):1006-1015. PubMed ID: 27943242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of co-purifying CHO host cell proteins in monoclonal antibody purification process.
    Liu X; Chen Y; Zhao Y; Liu-Compton V; Chen W; Payne G; Lazar AC
    J Pharm Biomed Anal; 2019 Sep; 174():500-508. PubMed ID: 31234041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of an IgG CDR sequence contributing to co-purification of the host cell protease cathepsin D.
    Bee JS; Machiesky LM; Peng L; Jusino KC; Dickson M; Gill J; Johnson D; Lin HY; Miller K; Heidbrink Thompson J; Remmele RL
    Biotechnol Prog; 2017 Jan; 33(1):140-145. PubMed ID: 27798957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host cell protein impurities in chromatographic polishing steps for monoclonal antibody purification.
    Levy NE; Valente KN; Lee KH; Lenhoff AM
    Biotechnol Bioeng; 2016 Jun; 113(6):1260-72. PubMed ID: 26550778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymer-mediated flocculation of transient CHO cultures as a simple, high throughput method to facilitate antibody discovery.
    Schmitt MG; Rajendra Y; Hougland MD; Boyles JS; Barnard GC
    Biotechnol Prog; 2017 Sep; 33(5):1393-1400. PubMed ID: 28722325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel approach to characterize host cell proteins associated with therapeutic monoclonal antibodies.
    Thomson AS; Mai S; Byrne MP
    Biotechnol Bioeng; 2017 Jun; 114(6):1208-1214. PubMed ID: 28112396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of robust host cell protein clearance in biopharmaceutical downstream processes.
    Shukla AA; Jiang C; Ma J; Rubacha M; Flansburg L; Lee SS
    Biotechnol Prog; 2008; 24(3):615-22. PubMed ID: 18410156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a host cell protein impurity in therapeutic protein, P1.
    Ahluwalia D; Dhillon H; Slaney T; Song H; Boux H; Mehta S; Zhang L; Valdez A; Krishnamurthy G
    J Pharm Biomed Anal; 2017 Jul; 141():32-38. PubMed ID: 28419935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted CHO cell engineering approaches can reduce HCP-related enzymatic degradation and improve mAb product quality.
    Dovgan T; Golghalyani V; Zurlo F; Hatton D; Lindo V; Turner R; Harris C; Cui T
    Biotechnol Bioeng; 2021 Oct; 118(10):3821-3831. PubMed ID: 34125434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of difficult-to-remove host cell protein impurities during extended Chinese hamster ovary cell culture and their impact on continuous bioprocessing.
    Valente KN; Lenhoff AM; Lee KH
    Biotechnol Bioeng; 2015 Jun; 112(6):1232-42. PubMed ID: 25502542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host cell protein dynamics in recombinant CHO cells: impacts from harvest to purification and beyond.
    Hogwood CE; Bracewell DG; Smales CM
    Bioengineered; 2013; 4(5):288-91. PubMed ID: 23328085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More similar than different: Host cell protein production using three null CHO cell lines.
    Yuk IH; Nishihara J; Walker D; Huang E; Gunawan F; Subramanian J; Pynn AF; Yu XC; Zhu-Shimoni J; Vanderlaan M; Krawitz DC
    Biotechnol Bioeng; 2015 Oct; 112(10):2068-83. PubMed ID: 25894672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host Cell Protein Profiling in Biopharmaceutical Harvests.
    Obrstar D; Kröner F; Japelj B; Bojic L; Anderka O
    Anal Chem; 2018 Oct; 90(19):11240-11247. PubMed ID: 30048127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mild hypothermic culture conditions affect residual host cell protein composition post-Protein A chromatography.
    Goey CH; Bell D; Kontoravdi C
    MAbs; 2018 Apr; 10(3):476-487. PubMed ID: 29381421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ELISA reagent coverage evaluation by affinity purification tandem mass spectrometry.
    Henry SM; Sutlief E; Salas-Solano O; Valliere-Douglass J
    MAbs; 2017 Oct; 9(7):1065-1075. PubMed ID: 28708446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive assessment of host cell protein expression after extended culture and bioreactor production of CHO cell lines.
    Hamaker NK; Min L; Lee KH
    Biotechnol Bioeng; 2022 Aug; 119(8):2221-2238. PubMed ID: 35508759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating Immunogenicity Risk Due to Host Cell Protein Impurities in Antibody-Based Biotherapeutics.
    Jawa V; Joubert MK; Zhang Q; Deshpande M; Hapuarachchi S; Hall MP; Flynn GC
    AAPS J; 2016 Nov; 18(6):1439-1452. PubMed ID: 27450229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving the efficiency of CHO cell line generation using glutamine synthetase gene knockout cells.
    Fan L; Kadura I; Krebs LE; Hatfield CC; Shaw MM; Frye CC
    Biotechnol Bioeng; 2012 Apr; 109(4):1007-15. PubMed ID: 22068567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.